MoneyWorks4Me

Windlas Biotech - Quaterly Results

08 Feb 2024 Evaluate
The sales surged to Rs. 1622.13 millions, up 35.51% for the December 2023 quarter as against Rs. 1197.04 millions during the corresponding quarter previous year.Net profit surges 64.32% to Rs. 150.98  millions  from Rs. 91.88 millions in the quarter ended December 2023.The company reported a good operating profit of 235.01 millions compared to 161.11 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 1622.13 1197.04 35.51 4596.71 3723.70 23.44 5130.83 4659.30 10.12
Other Income 31.64 21.62 46.35 90.28 76.31 18.31 99.65 67.06 48.60
PBIDT 235.01 161.11 45.87 651.95 514.31 26.76 702.07 596.01 17.80
Interest 3.05 1.57 94.27 8.27 6.22 32.96 7.86 14.17 -44.53
PBDT 231.96 159.54 45.39 643.68 508.09 26.69 694.21 581.84 19.31
Depreciation 33.89 31.35 8.10 99.08 87.96 12.64 123.64 121.47 1.79
PBT 198.07 128.19 54.51 544.60 420.13 29.63 570.57 460.37 23.94
TAX 47.09 36.31 29.69 132.65 108.16 22.64 144.13 74.76 92.79
Deferred Tax 2.39 8.65 -72.37 4.42 6.75 -34.52 0.63 -26.57 -102.37
PAT 150.98 91.88 64.32 411.95 311.97 32.05 426.44 385.61 10.59
Equity 103.99 107.21 -3.00 103.99 108.97 -4.57 104.63 108.97 -3.98
PBIDTM(%) 14.49 13.46 7.64 14.18 13.81 2.69 13.68 12.79 6.97
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..